Doctors from around the world recently teamed up to study a new pill that could help people with type 2 diabetes manage their blood sugar more effectively. This large study took place in 14 countries at 177 different hospitals and clinics. The lead researcher was Dr. Vanita R. Aroda from a hospital in Boston.
The goal of the study was to find out how well a medicine called semaglutide works when taken every day. Semaglutide is already used for diabetes in a weekly injection form, but this study looked at it in pill form. It’s designed to help lower blood sugar levels in people with type 2 diabetes, which is a condition where the body struggles to manage sugar in the blood.
In the study, participants had a blood sugar marker called HbA1c between 8.0 and 10.5 percent, which means their diabetes was not well controlled. HbA1c is a simple test that shows a person’s average blood sugar level over the past three months. These participants were also taking one to three different diabetes pills each day but still needed better control of their blood sugar.
To test semaglutide, people were divided into three groups. One group took 14 milligrams a day, another took 25 mg, and the third group took 50 mg. Everyone continued the treatment for 68 weeks, which is just over a year. The main question was: Would semaglutide help lower their HbA1c levels after one year?
The results were clear. All three doses helped reduce blood sugar levels, but the 25 mg and 50 mg doses worked significantly better than the 14 mg dose. In short, the higher the dose, the more blood sugar dropped. On top of that, people taking the higher doses also lost more weight, which is another major benefit for people with type 2 diabetes.
Like most medicines, semaglutide came with some side effects. The most common ones were stomach-related, such as nausea or mild stomach pain. These side effects happened more often in the groups taking the 25 mg and 50 mg doses. However, most side effects were mild and didn’t last long.
In simple terms, this study showed that higher daily doses of semaglutide (25 mg or 50 mg) helped people lower their blood sugar more effectively than the lower dose. They also experienced some weight loss, which can help improve overall health.
While some people did feel a bit sick to their stomach, the benefits of better blood sugar control may outweigh these temporary issues for many patients.
This research is exciting because it offers a daily pill option for people with type 2 diabetes who may not want or be able to take weekly injections. It could become an important new tool for managing diabetes more effectively around the world.
The study was published in The Lancet, one of the world’s leading medical journals. If you’re interested in diabetes research, other recent studies have explored new drug options, the possible effects of cannabis on diabetes risk, and how vitamins like Vitamin E might protect the brain from diseases like Parkinson’s.
As always, if you or someone you know is managing diabetes, talk to a healthcare provider before starting or changing any treatments.
If you care about diabetes, please read studies about a cure for type 2 diabetes, and these vegetables could protect against kidney damage in diabetes.
For more information about diabetes, please see recent studies about bone drug that could lower risk of type 2 diabetes, and results showing eating more eggs linked to higher risk of type 2 diabetes.
Copyright © 2025 Knowridge Science Report. All rights reserved.
